Key result
Combined treatment with delapril and indapamide prevented aortic fibrosis in salt-loaded stroke-prone spontaneously hypertensive rats, independent of blood pressure reduction.
Why the study?
Does combined treatment with delapril and indapamide prevent aortic fibrosis in salt-loaded stroke-prone spontaneously hypertensive rats?
Does combined treatment with delapril and indapamide prevent aortic fibrosis in salt-loaded stroke-prone spontaneously hypertensive rats?
The combination of delapril and indapamide limits aortic fibrosis in hypertensive rats independent of blood pressure reduction.
Answers are grounded in this paper and cite their sources.
May indicate BP-independent aortic protection in hypertensive models; leaves open translation to human disease.
Combined treatment with the angiotensin-converting enzyme (ACE) inhibitor delapril and the diuretic indapamide prevented vascular damage in vital organs of salt-loaded stroke-prone spontaneously hypertensive rats (SHRsp). Whether the changes occurring after long-term hypertension could also be modulated in large arteries was investigated. Two-month-old SHRsp were salt loaded and treated with the drug regimen until they reached 50% mortality or around midlife. In a first experiment, delapril (12 mg/kg) and indapamide (1 mg/kg) were administered daily separately or in combination. In the second dose-finding experiment, delapril (6, 3, 1.5 mg/kg) and indapamide (0.5, 0.25, 0.125 mg/kg) in decreasing dose combinations were analyzed. Ultrastructural, histomorphometric, and biochemical studies were performed on the thoracic aorta. When compared with delapril (12 mg/kg) or indapamide (1 mg/kg) administered individually for 5 months, the combination 12 + 1 mg/kg was able to prevent the increase in extracellular matrix deposition observed in other treatment groups, as assessed by histomorphometry or 4-OH-proline biochemical determination. In the second experiment, a half-dose (delapril 6 mg/kg + indapamide 0.5 mg/kg) combination was similarly effective in counteracting fibrosis, but the other doses progressively failed. In the first experiment, the combination had a stabilizing effect on hypertension and stimulated diuresis. In the second experiment, arterial blood pressure values and sodium balance were not consistently affected by the treatments that antagonized fibrosis (i.e., delapril 6 mg/kg + indapamide 0.5 mg/kg and, less efficiently, delapril 3 mg/kg + indapamide 0.25 mg/kg). These results suggest that indapamide interacts with ACE inhibitors to limit aortic fibrosis independent of any well-established mechanism.
No takes yet. Share an insight, caveat, or question.
Contri et al. (2002) studied Hypertension. Combined delapril and indapamide vs. Delapril alone, indapamide alone, or lower dose combinations was evaluated on Extracellular matrix deposition (aortic fibrosis). Combined treatment with delapril and indapamide prevented aortic fibrosis in salt-loaded stroke-prone spontaneously hypertensive rats, independent of blood pressure reduction.
Synapse has enriched 10 related papers. Consider them for comparative context: